Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Immunology

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830210403PMID 1902177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immunology of diabetes mellitus

  1991cited by this paper
• Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.

  1990cited by this paper
• Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain

  1990cited by this paper
• Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice

  1990cited by this paper
• The cascading, interrelated roles of interleukin-1, interleukin-2, and interleukin-6 in murine anti-CD3-driven T cell proliferation.

  1990cited by this paper
• Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.

  1990cited by this paper
• Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

  1989cited by this paper
• Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

  1989cited by this paper
• T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice

  1989cited by this paper
• In-vivo anti-CD3 treatment of autoimmune patients.

  1989cited by this paper
• The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells

  1989cited by this paper
• An explanation for the protective effect of the MHC class II I–E molecule in murine diabetes

  1989cited by this paper
• Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning

  1989cited by this paper
• Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.

  1989cited by this paper
• INTERLEUKIN‐2-DIPHTHERIA TOXIN FUSION PROTEIN PROLONGS MURINE ISLET CELL ENGRAFTMENT

  1989cited by this paper
• Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice

  1988cited by this paper
• Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions

  1988cited by this paper
• Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat.

  1988cited by this paper
• Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity.

  1988cited by this paper
• Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.

  1988cited by this paper
• Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice

  1988cited by this paper
• Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

  1988cited by this paper
• Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

  1988cited by this paper
• A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis

  1988cited by this paper
• HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

  1987cited by this paper
• HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

  1987cited by this paper
• Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice

  1987cited by this paper
• Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells

  1987cited by this paper
• The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

  1987cited by this paper
• Identification of a monoclonal antibody specific for a murine T3 polypeptide.

  1987cited by this paper
• Direct evidence for the existence of nominal antigen binding sites on T cell surface Ti alpha-beta heterodimers of MHC-restricted T cell clones.

  1986cited by this paper
• Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

  1986cited by this paper
• Preventive effects of Cyclosporin on diabetes in NOD mice

  1986cited by this paper
• Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice

  1986cited by this paper
• An overview of T-suppressor cell circuits.

  1986cited by this paper
• Direct evidence for the existence of nominal antigen binding sites on T cell surface Ti α-β heterodimers of MHC-restricted T cell clones

  1986cited by this paper
• Insulitis and type I diabetes : lessons from the NOD mouse

  1986cited by this paper
• Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

  1986cited by this paper
• Genetic analysis for insulitis in NOD mice.

  1985cited by this paper
• Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

  1985cited by this paper
• In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

  1985cited by this paper
• The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice

  1985cited by this paper
• The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype

  1984cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper

• Diabetogenic T Cells from Transgenic Decarboxylase 65 Sequence, that Stimulate Peptide Ligands, Including a Glutamic Acid Identification of MHC Class II-Restricted

  2013cites this paper
• The Class I HLA Repertoire of Pancreatic Islets Comprises the Nonclassical Class Ib Antigen HLA-G

  2006cites this paper
• NKT Cells and Autoimmune Type 1 Diabetes

  2005cites this paper
• The immunologic insult in type 1 diabetes

  2004cites this paper
• Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

  2004cites this paper
• Mechanism of self-tolerance to endocrine tissue

  2004cites this paper
• Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

  2003cites this paper
• Immunoregulation by cytokines in autoimmune diabetes.

  2003cites this paper
• Expression of a Tumor Necrosis Factor cr Transgene in Murine Pancreatic / 3 Cells Results in Severe and Permanent InsuHtis without Evolution towards Diabetes

  2003cites this paper
• Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1

  2001cites this paper
• Approaches to Type 1 Diabetes Prevention by Intervention in Cytokine Immunoregulatory Circuits

  2001cites this paper
• Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice

  2001cites this paper
• Regulatory T cells in autoimmmunity*.

  2000influential citation
• Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse1

  2000cites this paper
• Transgenic Mouse Mice by Th 2 T Cell Clones from a TCR Induction of Diabetes in Nonobese Diabetic

  2000cites this paper
• Type 1 diabetes: the facts fit a deficient inhibitory signal given by MHC Class II

  1999cites this paper
• The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

  1999cites this paper
• Genetic regulation of contingent macrophage- and T-cell-dependent steps in islet inflammation

  1999cites this paper
• The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse

  1999cites this paper
• Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.

  1999cites this paper
• Immunologic approaches in the prevention and treatment of type 1 diabetes and endocrine autoimmune diseases.

  1999cites this paper
• MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesis.

  1998cites this paper
• Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies

  1998cites this paper
• The B-Subunit of Cholera Toxin Induces Immunoregulatory Cells and Prevents Diabetes in the NOD Mouse

  1998cites this paper
• Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.

  1998cites this paper
• Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.

  1997cites this paper
• The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse.

  1997cites this paper
• Autoreactive T-Cell Clones from the Nonobese Diabetic Mouse

  1997cites this paper
• Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse

  1997cites this paper
• A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.

  1997cites this paper
• Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells.

  1997cites this paper
• Mechanism underlying counterregulation of autoimmune diabetes by IL-4.

  1997cites this paper
• Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice.

  1997cites this paper
• Autoimmune diabetes: how many steps for one disease?

  1997cites this paper
• Association Between αβTCR+CD4−CD8− T-Cell Deficiency and IDDM in NOD/Lt Mice

  1997cites this paper
• A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.

  1996cites this paper
• Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

  1996cites this paper
• Diabetes mellitus induced by low-dose interleukin-2

  1996cites this paper
• Diabetogenic T-Cell Clones

  1996cites this paper
• Differential involvement of Th1 and Th2 cytokines in autoimmune diseases.

  1996cites this paper
• Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation.

  1995cites this paper
• Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass

  1995cites this paper
• Islet-Infiltrating Lymphocytes from Prediabetic NOD Mice Rapidly Transfer Diabetes to NOD-scid/scid mice

  1995cites this paper
• Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

  1995cites this paper
• Induction of Insulitis in Athymic (Nude) Mice: The Effect of NOD Thymus and Pancreas Transplantation

  1995cites this paper
• Cytokines as mediators of autoimmune diabetes and diabetic complications.

  1995cites this paper
• Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis.

  1995cites this paper
• Autoimmune Mechanisms in The Etiology of Type I Diabetes

  1994cites this paper
• Activation of autoreactive T-lymphocytes by cultured syngeneic glomerular mesangial cells.

  1994cites this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cites this paper
• In pursuit of the "holy grail": allograft tolerance.

  1994cites this paper
• Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice.

  1994cites this paper
• Evidence of CD4 + regulatory T cells in the non-obese diabetic male mouse

  1994cites this paper
• Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

  1994cites this paper
• Transgenic mice carrying the rearranged T cell receptor of a diabetogenic T cell clone

  1994cites this paper
• Adoptive transfer of autoimmune diabetes mellitus to athymic rats: synergy of CD4+ and CD8+ T cells and prevention by RT6+ T cells.

  1994cites this paper
• Following a diabetogenic T cell from genesis through pathogenesis.

  1993cites this paper
• The NOD Mouse: A Model for Analyzing the Interplay Between Heredity and Environment in Development of Autoimmune Disease

  1993cites this paper
• Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors

  1993cites this paper
• Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice.

  1993cites this paper
• Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line

  1993influential citation
• Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice.

  1993cites this paper
• Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments.

  1993cites this paper
• Complement Lytic Activity Has No Role in the Pathogenesis of Autoimmune Diabetes in NOD Mice

  1993cites this paper
• Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases.

  1993cites this paper
• A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice

  1993cites this paper
• T-cell compartment involvement in two high antibody responder lines of mice (HI and HII Biozzi mice) respectively susceptible and resistant to collagen-induced arthritis.

  1993cites this paper
• Autoimmune diabetes results from genetic defects manifest by antigen presenting cells

  1993cites this paper
• Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.

  1993cites this paper
• Characterization of T Lymphocytes Infiltrating Human Pancreas Allograft Affected by Isletitis and Recurrent Diabetes

  1992cites this paper
• Autoantigens in thyroid and islet autoimmunity: similarities and differences.

  1992cites this paper
• The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects

  1992cites this paper
• A protective NOD islet‐infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties

  1992cites this paper
• Interleukin 2 receptor targeted fusion toxin (DAB486‐IL‐2) treatment blocks diabetogenic autoimmunity in non‐obese diabetic mice

  1992cites this paper
• Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes

  1992cites this paper
• An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.

  1992cites this paper
• Enhanced tumor necrosis factor in anti-CD3 antibody stimulated diabetic NOD mice: modulation by PGE1 and dietary lipid.

  1992cites this paper
• The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain.

  1991cites this paper
• Perspectives in Diabetes The Absence of a Glycemic Threshold for the Development of ~ o n g-~ e r m Complications : The Perspective of the Diabetes Control and

  year unknowncites this paper